Overview


According to FutureWise analysis the market for animal drug compounding is expected to reach US$ 4.08 billion by 2031 at a CAGR of 8.4%.

Animal drug compounding is a practice of combining, altering, or mixing ingredients to create a medication tailored for the use of an individual or small group of animals. This drug plays a vital role in veterinary medicine. When the source of active ingredient to be used in compounding medications is a finished FDA- Approved drug and not a bulk drug, it is permitted by the Federal Food, Drug, and Cosmetic Act (FD & C Act). Pharmacists or veterinarians are the trained persons who make them. Animal drugs compounded from bulk drugs, which is a substance used to create a drug that becomes an active ingredient in the final dosage form of the drug, are not FDA- approved and have not been reviewed by the FDA for the evidence of safety, properly manufactured, effective, accurately labelled, and adequately packaged.

Animal drug compounding is done for many reasons, some of which are Dosage Adjustments, where the commercially available medicines are manufactured in a specific dose, which differs from animal to animal, and ineffective working due to differences in size or health conditions. Due to compounding, there is a greater chance to care for the animal's needs by adjusting the dosage as required. Furthermore, many medications with bitter tastes make it challenging to administer the dose to animals. Still, the flavoring is a method that can appeal to the animals, making it easier to administer it to animals. Certain drugs can be allergic to some animals, which can be resolved using animal compounding to reduce the risk of adverse reactions. It is essential that licensed pharmacists or veterinarians should carry out animal drug compounding in compounding pharmacies.

FutureWise Market Research has published a report that provides an insightful analysis of Animal drug compounding market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Animal drug compounding market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Wedgewood Pharmacy
  • Triangle Compounding Pharmacy
  • Davis Islands Pharmacy
  • Custom Med Compounding Pharmacy
  • Central Compounding Center South
  • Wellness Pharmacy of Cary
  • Caringbah Compounding Pharmacy
  • Millers Pharmacy
  • Smith's Pharmacy
  • Specialist Compounding Pharmacy Pte., Ltd.
  • Tache Pharmacy

(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent Development by the Key player in Animal drug compounding

  • Wedgewood Pharmacy recently acquired full- service testing facility front range laboratories (FRL) in Loveland, Colorado.it performs analytical and microbiological testing, product stability testing, and other service to serve the testing needs of pharmacies nationwide. Wedgewood pharmacies intends to preserve the FRL brand, which is reversed across the compounding pharmacy industry as a source of superior services, in February 2023

The animal drug compounding market is driven by many factors, which count as customization for an individual animal with specific drug allergies, and other problems can also be sustained by taking modified or altered drugs that can best suit them without any harm and fulfill their requirement. Advancement in compounding techniques by manufacturers, pharmacists, and veterinarians has also propelled the market revenue growth creating new options for the usage of animal compounding. Furthermore, enhancing flavor by the manufacturers has again driven the market growth as it has widely created more choices and drug acceptance; treatment of uncommon and exotic or less common species is also made available through animal drug compounding, which is an excellent opportunity for market growth.

However, some significant constraints are anticipated to restrain overall market growth to a certain extent over the projected period, including a need for more awareness and understanding of the disease among certain breeds of animals. Regulatory challenges made by FDA can be burdensome and costly for the compounding market and may vary from country to country. Changes in specific regulations can be challenging for market growth. Limited research and data and a lack of clinical studies make it challenging for veterinarians and pet owners to make firm decisions based on the correct medicine use, restraining the market growth.

By Product

  • Anti-infectives
    • Metronidazole
    • Ketoconazole
    • Other Antibiotics
  • Anti-inflammatory
    • Prednisolone
    • Tramadol
    • Other Anti inflammatory
  • CNS Agents
    • Potassium bromide
    • Gabapentin
    • Other CNS agents
  • GI Drugs
    • Apomorphine
    • Ursodiol
    • Cisapride
    • Other GI Drugs
  • Others
    • Methimazole
    • Other drugs

By Animal Type

  • Companion Animal
    • Dogs
    • Cats
    • Others
  • Livestock Animal

By Dosage Form

  • Capsule
  • Suspension
  • Solution
  • Powders
  • Others

By Route of Administration

  • Oral
  • Injectable
  • Topical
  • Rectal
  • Ocular

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. In 2022, the North American market had the highest revenue share, which can be attributed to factors such as a rise in pet ownership, strategic initiatives taken by major manufacturers, and frequent product launches in the region. For example, Chewy, Inc., a leader in pet e-commerce, expanded its Pharmacy (Rx) division in November 2020 to offer customized animal drugs to cater to individual pet needs. The Asia Pacific region is expected to grow at the fastest rate during the forecast period. This growth is mainly due to an increase in pet humanization, higher spending on animal healthcare, and the availability of low-cost compounded medications for animals. Additionally, global players are investing more in this region to expand their presence, and there is a rise in demand for compounded veterinary medications, especially for pets and non-food-producing animals, which is expected to boost market growth. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Animal Drug Compounding Market By Product, By Animal Type, By Dosage Form, By Route of Administration and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Animal Drug Compounding Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Drug Compounding Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Animal Drug Compounding Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Animal Drug Compounding Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Anti-infectives
         1.1. Metronidazole
         1.2. Ketoconazole
         1.3. Other Antibiotics
        2. Anti-inflammatory
         2.1. Prednisolone
         2.2. Tramadol
         2.3. Other Anti inflammatory
        3. CNS Agents
         3.1. Potassium bromide
         3.2. Gabapentin
         3.3. Other CNS agents
        4. GI Drugs
         4.1. Apomorphine
         4.2. Ursodiol
         4.3. Cisapride
         4.4. Other GI Drugs
        5. Others
         5.1. Methimazole
         5.2. Other drugs

  • 8.   Global Animal Drug Compounding Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Companion Animal
         1.1.Dogs
         1.2.Cats
         1.3.Others
        2. Livestock Animal

  • 9.   Global Animal Drug Compounding Market, By Dosage Form Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Capsule
        2. Suspension
        3. Solution
        4. Powders
        5. Others

  • 10.   Global Animal Drug Compounding Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Injectable
        3. Topical
        4. Rectal
        5. Ocular

  • 11.   North America Animal Drug Compounding Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Animal Drug Compounding Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Animal Drug Compounding Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Animal Drug Compounding Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Wedgewood Pharmacy
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Triangle Compounding Pharmacy
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Davis Islands Pharmacy
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Custom Med Compounding Pharmacy
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Central Compounding Center South
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Wellness Pharmacy of Cary
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Caringbah Compounding Pharmacy
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Millers Pharmacy
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Smith's Pharmacy
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Specialist Compounding Pharmacy Pte., Ltd.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Tache Pharmacy
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Related Market

Animal Drugs Market

Read More
Partner

Our Clients